GHermange's profile picture. Maître de conférences in Applied Mathematics & Health @centralesupelec and @GustaveRoussy

Gurvan Hermange

@GHermange

Maître de conférences in Applied Mathematics & Health @centralesupelec and @GustaveRoussy

You might like
Gurvan Hermange reposted

Sopa is now published, read the paper and try it out on your own spatial data!👇 nature.com/articles/s4146…


Gurvan Hermange reposted

A few words (2) of Oral communication by Gurvan Hermange @GHermange @Perielab1 @BiomathCS @BioRugby at #CHO2023 #MathematicalModelling #HSCA

CHO_HEMATO's tweet image. A few words (2) of Oral communication by Gurvan Hermange @GHermange @Perielab1 @BiomathCS @BioRugby at #CHO2023
#MathematicalModelling #HSCA

Gurvan Hermange reposted

Large study of RNA-seq in pts w refractory metastatic cancer (n=1031). Pan-cancer analyses. Key msg: high nb of actionable fusions, especially located on PTEN. Certainly a good starting point to evaluate clinical utility of RNA-seq.

FAndreMD's tweet image. Large study of RNA-seq in pts w refractory metastatic cancer (n=1031). Pan-cancer analyses.

Key msg: high nb of actionable fusions, especially located on PTEN. Certainly a good starting point to evaluate clinical utility of RNA-seq.

The pan-cancer cohort (META-PRISM) of 1,031 refractory metastatic tumors profiled via whole-exome and transcriptome sequencing is now published #OpenAccess in @CD_AACR aacrjournals.org/cancerdiscover… @FAndreMD

Aiims1742's tweet image. The pan-cancer cohort (META-PRISM) of 1,031 refractory metastatic tumors profiled via whole-exome and transcriptome sequencing is now published #OpenAccess in @CD_AACR 
aacrjournals.org/cancerdiscover…
@FAndreMD


Gurvan Hermange reposted

How have US Twitter users responded to fluctuating mask recommendations from public health agencies during the pandemic? That is what our research team investigated, using interrupted time series and sentiment/emotion analyses. Check our recent JMIR study: lnkd.in/eTzMhCQh


Gurvan Hermange reposted

Such exciting data for patients with CALRmut MPNs. A great example of how industry-academia collaborations can accelerate development of novel therapies. Lovely work from Edimara Reis and colleagues @Incyte @hitchcock_lab @isabelle_plo and others

beth_psaila's tweet image. Such exciting data for patients with CALRmut MPNs. A great example of how industry-academia collaborations can accelerate development of novel therapies. Lovely work from Edimara Reis and colleagues @Incyte @hitchcock_lab @isabelle_plo and others
beth_psaila's tweet image. Such exciting data for patients with CALRmut MPNs. A great example of how industry-academia collaborations can accelerate development of novel therapies. Lovely work from Edimara Reis and colleagues @Incyte @hitchcock_lab @isabelle_plo and others
beth_psaila's tweet image. Such exciting data for patients with CALRmut MPNs. A great example of how industry-academia collaborations can accelerate development of novel therapies. Lovely work from Edimara Reis and colleagues @Incyte @hitchcock_lab @isabelle_plo and others
beth_psaila's tweet image. Such exciting data for patients with CALRmut MPNs. A great example of how industry-academia collaborations can accelerate development of novel therapies. Lovely work from Edimara Reis and colleagues @Incyte @hitchcock_lab @isabelle_plo and others

Gurvan Hermange reposted

Les hémopathies sont des maladies qui induisent un dérèglement de l’hématopoïèse. Les comprendre et ce pour chaque individu, est essentiel pour une prise en charge optimale des patients bit.ly/3gRwgHd

Hematologie_JLE's tweet image. Les hémopathies sont des maladies qui induisent un dérèglement de l’hématopoïèse. Les comprendre et ce pour chaque individu, est essentiel pour une prise en charge optimale des patients bit.ly/3gRwgHd
Hematologie_JLE's tweet image. Les hémopathies sont des maladies qui induisent un dérèglement de l’hématopoïèse. Les comprendre et ce pour chaque individu, est essentiel pour une prise en charge optimale des patients bit.ly/3gRwgHd
Hematologie_JLE's tweet image. Les hémopathies sont des maladies qui induisent un dérèglement de l’hématopoïèse. Les comprendre et ce pour chaque individu, est essentiel pour une prise en charge optimale des patients bit.ly/3gRwgHd

Gurvan Hermange reposted

WES & RNAseq landscape of > 1,000 multi-resistant tumors treated @GustaveRoussy highlights the current gap in understanding treatment resistances. Preprint medrxiv.org/cgi/content/sh…. Data will be made available upon release in peer-reviewed journal. @centralesupelec @PrismCenter.

ypradat's tweet image. WES & RNAseq landscape of > 1,000 multi-resistant tumors treated @GustaveRoussy highlights the current gap in understanding treatment resistances. Preprint medrxiv.org/cgi/content/sh…. Data will be made available upon release in peer-reviewed journal. @centralesupelec @PrismCenter.
ypradat's tweet image. WES & RNAseq landscape of > 1,000 multi-resistant tumors treated @GustaveRoussy highlights the current gap in understanding treatment resistances. Preprint medrxiv.org/cgi/content/sh…. Data will be made available upon release in peer-reviewed journal. @centralesupelec @PrismCenter.
ypradat's tweet image. WES & RNAseq landscape of > 1,000 multi-resistant tumors treated @GustaveRoussy highlights the current gap in understanding treatment resistances. Preprint medrxiv.org/cgi/content/sh…. Data will be made available upon release in peer-reviewed journal. @centralesupelec @PrismCenter.
ypradat's tweet image. WES & RNAseq landscape of > 1,000 multi-resistant tumors treated @GustaveRoussy highlights the current gap in understanding treatment resistances. Preprint medrxiv.org/cgi/content/sh…. Data will be made available upon release in peer-reviewed journal. @centralesupelec @PrismCenter.

Gurvan Hermange reposted

4 yrs ago, we discussed with Mathematicians ⁦@centralesupelec⁩ about integrating Maths in Cancer Research projects⁩. It’s nice to see papers coming on Mathematical models of cancer from our teams. Here a modeling of myeloproliferative disorders 👇 pnas.org/doi/10.1073/pn…


Very pleased to announce that our paper "Inferring the initiation and development of Myeloproliferative Neoplasms" has been published in PNAS: pnas.org/doi/10.1073/pn… #MPN


Gurvan Hermange reposted

Hematopoiesis in numbers - check out this #opinion from researchers at @Perielab1 @institut_curie @HustinLucie @cosgrove47 @TrendsImmuno #ISSCR2022 hubs.li/Q01dFR_Y0


Happy to share the pre-print of our methodological work, in collaboration with @isabelle_plo et al., on mathematical modelling and model selection for inferring the minimal dose in IFNα therapy against #MPN arxiv.org/abs/2112.10688


Gurvan Hermange reposted

Inferring the dynamics of mutated hematopoietic stem and progenitor cells induced by IFNα in myeloproliferative neoplasms loom.ly/8-2JNgc

BloodPortfolio's tweet image. Inferring the dynamics of mutated hematopoietic stem and progenitor cells induced by IFNα in myeloproliferative neoplasms loom.ly/8-2JNgc

Very pleased to see our paper on inferring the hematopoietic dynamics over IFN therapy, published in this issue of Blood!

The newest issue of Blood is now available! Happy 75 years to Blood! loom.ly/bohTfiQ #hematology #75yearsofbloodjournal

BloodPortfolio's tweet image. The newest issue of Blood is now available! Happy 75 years to Blood! loom.ly/bohTfiQ #hematology #75yearsofbloodjournal


Glad to see the results of our work in collaboration with @isabelle_plo and her team at @GustaveRoussy published in @BloodJournal. doi.org/10.1182/blood.…


Gurvan Hermange reposted

Important information that may help in the understanding of clonal evolution during interferon therapy in JAK2 and CALR mutated MPNs Great collaboration with @isabelle_plo @FimMpn @cerubidine doi.org/10.1182/blood.…


Gurvan Hermange reposted

A very interesting crop of #cancer papers today in @nature exploring dormancy, cell competition, stem cell niches (h/t @BarbMarte). Thread👇


Gurvan Hermange reposted

Classement thématique #Shanghai2021 @UnivParisSaclay conforte sa position d'université de #Recherche intensive de rang international: 🏆1ère en #Mathématique (Monde) 🏆1ère en #Physique (Europe) ...et dans le Top 50 mondial pour 11 disciplines ! 👉 bit.ly/3yOqZEm

UnivParisSaclay's tweet image. Classement thématique #Shanghai2021 @UnivParisSaclay conforte sa position d'université de #Recherche intensive de rang international:
🏆1ère en #Mathématique (Monde)
🏆1ère en #Physique (Europe)
...et dans le Top 50 mondial pour 11 disciplines !
👉 bit.ly/3yOqZEm

Gurvan Hermange reposted

[#Podcast] IA et cancer, le diagnostic infaillible ? bit.ly/3eixKoB à (ré)écouter via @franceculture #LaMethSci

ScienceCQFD's tweet image. [#Podcast] IA et cancer, le diagnostic infaillible ? bit.ly/3eixKoB à (ré)écouter via @franceculture #LaMethSci

Nous étions ravis d'accueillir ce matin Robert Bossy de @INRAE_MaIAGE pour présenter ses travaux à nos étudiants en maths de @centralesupelec et clôturer notre concours bibliographique !


Gurvan Hermange reposted

En cette #JournéeMondialeDeLaSanté comme tous les jours de l’année, nous mettons toute notre énergie au service de nos patients pour leur apporter les meilleurs soins possibles contre le #cancer et faire progresser la recherche médicale pour tous 🤝

GustaveRoussy's tweet image. En cette #JournéeMondialeDeLaSanté comme tous les jours de l’année, nous mettons toute notre énergie au service de nos patients pour leur apporter les meilleurs soins possibles contre le #cancer et faire progresser la recherche médicale pour tous 🤝

United States Trends

Loading...

Something went wrong.


Something went wrong.